Neuro65/AOCN2024
May 29 - Jun 1, 2024Tokyo International Forum
Neuro65/AOCN2024
May 29 - Jun 1, 2024Tokyo International Forum
[Vpr]Development of heteroduplex oligonucleotide (HDO), a Novel Nucleic Acid Medicine
Takanori Yokota(Professor of Department of Neurology and Neurological Science, Tokyo Medical and Dental University / Director of NucleoTIDE and PepTIDE Drug Discovery Center, Japan)
Personal History:
1984-1985Resident in Internal Medicine, Tokyo Medical and Dental University
1985-1986Resident in Internal Medicine, Musashino Red Cross Hospital and Dental University
1990-1998Instructor in Neurology, Tokyo Medical and Dental University.
1998-1999Research Fellow in Bredesen's lab in Burham Institute (CA, USA)
1999-2000Research Fellow in Bredesen's lab in Buck Center for Aging Research (CA, USA)
2014-Professor in Neurology, Tokyo Medical and Dental University
Award:
2001Award of 42nd Japanese Neurological Association
2003Award of 56th Japanese Vitamin Association
2006Award of 18th Meeting of Japanese Society of Neuroimmunology
2021Award of 33th Meeting of Japanese Society of Neuroimmunology
2022Award of 18th Meeting of Oligonucleotide Therapeutics Society
2023The Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology, Awards for Science and Technology
Password required to view
Abstract password authentication.
You can find the password on page 15 of the program book.
You can find the password on page 15 of the program book.